Udayavni Special

Sun Pharma to launch complete range of generic anti-epilepsy drug

PTI, Feb 23, 2021, 4:28 PM IST

New Delhi: Sun Pharmaceutical Industries on Tuesday, February 23, said it plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the country at an affordable price.

The drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solution (10 mg/ml) and injectable (10 mg/ml) will be available in the market over the next few weeks.

Brivaracetam is approved by the Drugs Controller General of India (DCGI), as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.

”We are introducing the complete range of Brivaracetam in India at competitive pricing which will improve patient access. This product reaffirms our commitment towards improving epilepsy care by bringing multiple treatment options to patients and health care professionals in India,” Sun Pharma Chief Executive Officer – India Business Kirti Ganorkar said in a statement.

Brivaracetam belongs to the class of anti-epileptic drugs (AEDs) which have a unique or different mechanism of action compared to the existing treatment options. It has a fast onset of action and promising efficacy.

While epilepsy is a common neurological disorder, because of the social stigma surrounding the disease, cultural practices, and poor awareness of new treatment options, its management continues to be a challenge, the drug major said.

It is estimated that around 5.7 million to 6.4 million people in India suffer from epilepsy, it added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Rifts within Congress ahead of West Bengal elections

BJP surges ahead of Congress in Gujarat civic polls

Identity politics gain ground in West Bengal ahead of assembly polls

Premananda Shetty elected Mayor and Sumangala Rao as Deputy Mayor of Mangaluru

NGT directs Delhi Jal Board to control ‘bad odour’ emanating from Kondli sewage plant by May 31

India will invest USD 82 billion in port projects by 2035: PM Narendra Modi

Barred from being made Minister, Vishwanath now interested in entering Bigg Boss house

Related Articles More

Lamborghini’s SUV Urus crosses 100 units sales milestone in India

Mukesh Ambani tops Hurun India Rich List for 10th straight year

Toyota Kirloskar Motor registers 36% growth in domestic sales in Feb 2021

Escorts tractor sales up 30.6 pc at 11,230 units in Feb

Sensex surges over 500 pts in early trade; Nifty tops 14,680


VenkiPalimar​ | Chhatrapati Shivaji Maharaj Magazine Collage Video

Interview with Shree Harsha | Harshadhwani | Udayavani

Why is drinking Cold Water Bad for Health?

Ones I trusted the most, betrayed me: Dr. B. R Shetty

The entire COVID-19 Vaccination Process completed within 30 minutes

Latest Additions

Rifts within Congress ahead of West Bengal elections

Rahul Gandhi needs treatment: Shobha Karandlaje

Israel’s high court says non-Orthodox converts are Jews

BJP surges ahead of Congress in Gujarat civic polls

Identity politics gain ground in West Bengal ahead of assembly polls

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.